NBD-14270 | m-entrepreneurship.com

Product Name :
NBD-14270

Search keywords :
NBD-14270

drugId :
null

Target Vo:
Envelope glycoprotein gp160

Target Vo Short Name :
Envelope glycoprotein gp160

Moa_Name:
Envelope glycoprotein gp160 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
New York Blood Center

Active Company_Name :
New York Blood Center

Active Indication_Name:
HIV Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BrdU Antibody (YA578)
FKBP12 Antibody
HDAC4 Antibody (YA741): HDAC4 Antibody (YA741) is a non-conjugated and Mouse origined monoclonal antibody about 119 kDa, targeting to HDAC4 (4A3). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Author: Betaine hydrochloride

Related Posts